Thematic dimension | Frequency (percentage) |
---|---|
12 (63.2%) | |
6 (31.6%) | |
5 (26.3%) | |
7 (36.8%) | |
7 (36.8%) | |
Affordability [43,44,45, 47, 49,50,51,52,53,54,55, 57, 58, 60, 61] | 15 (78.9%) |
Vaccine price [43,44,45, 47, 49,50,51,52,53,54, 57, 58, 60, 61] | 14 (73.7%) |
4 (21.1%) | |
Awareness [43, 45,46,47,48,49,50,51,52,53,54,55,56,57,58, 60] | 16 (84.2%) |
Vaccine awareness [43, 45,46,47,48,49,50,51,52,53,54,55,56,57,58, 60] | 16 (84.2%) |
Acceptance [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58, 60] | 17 (89.5%) |
Vaccine safety and efficacy [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58, 60] | 17 (89.5%) |
Perceived susceptibility of being infected [43, 45,46,47, 49, 51, 52, 54, 56,57,58] | 11 (57.9%) |
9 (47.4%) | |
Interpersonal and media influence [43,44,45,46,47,48,49,50,51,52, 54,55,56,57, 60] | 15 (78.9%) |
2 (10.5%) | |
2 (10.5%) |